Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gjertsen

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
British Journal of Cancer|October 25, 2006
Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II studyS L Bernhardt, M K Gjertsen, S Trachsel, et al.
Experimental Dermatology|May 31, 2001
Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvantR E Hunger, C U Brand, M Streit, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2006
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancerPaal F Brunsvig, Steinar Aamdal, Marianne K Gjertsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2001
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancerI Saeterdal, J Bjørheim, K Lislerud, et al.
International Journal of Cancer|February 8, 1996
Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II studyM K Gjertsen, A Bakka, J Breivik, et al.
Diabetes Research and Clinical Practice|July 6, 2013
Triglycerides-diabetes association in healthy middle-aged men: modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia StudyP T Skretteberg, A N Grytten, K Gjertsen, et al.
International Journal of Cancer|April 6, 2001
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinomaM K Gjertsen, T Buanes, A R Rosseland, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
British Journal of Cancer|October 25, 2006
Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II studyS L Bernhardt, M K Gjertsen, S Trachsel, et al.
Experimental Dermatology|May 31, 2001
Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvantR E Hunger, C U Brand, M Streit, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2006
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancerPaal F Brunsvig, Steinar Aamdal, Marianne K Gjertsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2001
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancerI Saeterdal, J Bjørheim, K Lislerud, et al.
International Journal of Cancer|February 8, 1996
Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II studyM K Gjertsen, A Bakka, J Breivik, et al.
Diabetes Research and Clinical Practice|July 6, 2013
Triglycerides-diabetes association in healthy middle-aged men: modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia StudyP T Skretteberg, A N Grytten, K Gjertsen, et al.
International Journal of Cancer|April 6, 2001
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinomaM K Gjertsen, T Buanes, A R Rosseland, et al.
Pageof 2